Mayersohn Joel David bought CTOR
July 28, 2025 · Form 4 insider transaction
Mayersohn Joel David bought 21,228 shares of Citius Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 10 days after the transaction.
Direction
Acquired (buy-side)
Shares
21,228
Price
$0.00
Total value
N/A
InsiderMayersohn Joel David
Role—
CompanyCitius Oncology, Inc. (CTOR)
SecurityCommon Stock
Transaction codeJ: J
Transaction dateJuly 28, 2025
Filing dateAugust 7, 2025
Shares owned after21,228
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were acquired through a distribution in kind to limited partners of 10XYZ Holdings, which was the Sponsor of TenX Keane Acquisition ("TenX"), the legacy entity of Citius Oncology, Inc.